Header Logo

Connection

Haripriya Andanamala to Bevacizumab

Back to Details
This is a "connection" page, showing publications Haripriya Andanamala has written about Bevacizumab.
Haripriya Andanamala
Connection Strength
0.235
Bevacizumab
  1. The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study. Lancet Digit Health. 2026 Feb; 8(2):100952.
    View in: PubMed
    Score: 0.235
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.